Loading
Latest filing published 07 Oct 2022 for Dermata Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Andrew Seth Sandler, listed as board member, appears in our data through filings on Dermata Therapeutics, Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 7 April 2022 and the latest from 6 October 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 7 October 2022 with a share grant in Dermata Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations